Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...

Background and Objective: Escitalopram is the most selective serotonin reuptake inhibitor antidepressant; in contrast, duloxetine inhibits both serotonin and norepinephrine reuptake. Double-blind ...

drug escitalopram, suggests a systematic review and meta-analysis published in The BMJ today. The findings show that patients treated with high dose psilocybin showed better responses than those ...